Home News

DORIA® presentation

The fast onset of action long-acting injectable of risperidone. Based on our ISM® patented technology.

Wed, 25/10/2017 - 13:50 0 min
Download related document
No votes yet
 
Related
ROVI plants a forest with 2,000 trees in the Madrid Sierra
Madrid, 27 March 2023 Laboratorios Farmacéuticos ROVI and ReTree are collaborating to plant ROVI’s Forest in the Madrid Sierra. It is an...
3 min
27/03/2023
BioSim strengthens its national representation with the incorporation of ROVI...
Madrid, 21 March 2023 Laboratorios Farmacéuticos ROVI announces its incorporation as a member of the General Assembly of the Spanish...
3 min
21/03/2023
Full Year 2022 Results Press Release
ROVI REPORTS OPERATING REVENUE GROWTH OF 26% AND EBITDA GROWTH OF 37% Operating revenue increased by 26% to 817.7 million euros...
3 min
21/02/2023